Conferences - Results from #9620

Viewing 9621-9640 of 11721 articles

Cytoreductive Radical Prostatectomy cRP in men with hormone-naive, metastatic prostate cancer (mPCA) | EAU 2017:

EAU 2017: Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP)

EAU 2017: Predictors of early cancer specific and other cause mortality in high risk prostate cancer patients after radical prostatectomy: Results from a large, multi-institutional analysis

EAU 2017: Does nadir testosterone at the end of long term androgen deprivation therapy predict outcomes in high risk prostate cancer? Data from a phase III trial

EAU 2017: Extended pelvic lymph node dissection for intermediate-high risk prostate cancer: Frequency and distribution of nodal metastases

EAU 2017: Freedom from androgen deprivation and radiotherapy therapy after upfront minimally invasive surgery for high-risk prostate cancers

EAU 2017: Semi-ecologic, nationwide, population-based study of GnRH agonists, orchiectomy and risk of cardiovascular disease

EAU 2017: 4th ESO Prostate Cancer Observatory: The Urologists Perspective

EAU 2017: Assessing the 20-year outcomes of radical prostatectomy for high risk prostate cancer: Results from a large, multi-institutional series

EAU 2017: Improved recurrence-free survival in locally advanced prostate cancer after robot-assisted radical prostatectomy with 3D-cancer mapping constructed by MRI/US fusion biopsy

EAU 2017: 4th ESO Prostate Cancer Observatory: Innovation and Care in the Next 12 Months

SUFU 2017: Studies on Frality

SUFU 2017: Lower Urinary Tract Dysfunction Research Network

SUFU 2017: Best Practice Policy Statement on Urodynamic Antibiotic Prophylaxis in the Non-Index Patient

ASCO GU 2017: Best of Journals: Renal Cell Carcinoma – Medical Oncology - Session Highlights

ASCO GU 2017: Phase II trial of TI-CE high dose chemotherapy (HDCT) with drug monitoring for individual carboplatin dosing in patients with relapsed advanced germ cell tumors: A multicenter prospective GETUG trial. - Session Highlights

ASCO GU 2017: 111- A single-arm trial evaluating one cycle of BEP as adjuvant chemotherapy in high-risk, stage 1 non-seminomatous or combined germ cell tumors of the testis (NSGCTT). - Session Highlights

ASCO GU 2017: Dacomitinib (Daco) induction therapy for locally advanced (LA) or metastatic penile squamous cell carcinoma (PSCC): An open label, single-arm, phase II study. - Session Highlights

ASCO GU 2017: Muscle-invasive bladder cancer: Molecular subtypes and response to neoadjuvant chemotherapy. - Session Highlights

ASCO GU 2017: BC2001 long-term outcomes: A phase III randomized trial of chemoradiotherapy versus radiotherapy (RT) alone and standard RT versus reduced high-dose volume RT in muscle-invasive bladder cancer - Session Highlights

477
478
479
480
481
482
483
484
485
486